You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Pharmacol., 20 October 2021

Sec. Ethnopharmacology

Volume 12 - 2021 | https://doi.org/10.3389/fphar.2021.792330

Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation

  • 1. Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

  • 2. Shanghai Research Center of Biliary Tract Disease, Shanghai, China

  • 3. Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China

  • 4. Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  • 5. Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

  • 6. Faculty of Medicine, Imperial College London, London, United Kingdom

  • 7. Department of General Surgery, People’s Hospital of Gaoxin District, Suzhou, China

Article metrics

View details

5

Citations

1,2k

Views

839

Downloads

In the published article, there was an error in the affiliations order. Affiliations 1 and 3 were interchanged, and the superscript numbers 1 and 3 in the authors’ affiliations list were updated accordingly.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

isorhamnetin, gallbladder cancer, tumor progression, PI3K/Akt pathway, apoptosis

Citation

Zhai T, Zhang X, Hei Z, Jin L, Han C, Ko AT, Yu X and Wang J (2021) Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation. Front. Pharmacol. 12:792330. doi: 10.3389/fphar.2021.792330

Received

10 October 2021

Accepted

11 October 2021

Published

20 October 2021

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

12 - 2021

Updates

Copyright

*Correspondence: Xiaofeng Yu, ; Jiandong Wang,

†These authors have contributed equally to this work

This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics